Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 27504013)

Published in Diabetes on August 08, 2016

Authors

Kristine Færch1, Dorte Vistisen2, Giovanni Pacini3, Signe S Torekov4,5, Nanna B Johansen2,6, Daniel R Witte6,7, Anna Jonsson4, Oluf Pedersen4, Torben Hansen4, Torsten Lauritzen7, Marit E Jørgensen2, Bo Ahrén8, Jens Juul Holst4,5

Author Affiliations

1: Steno Diabetes Center, Gentofte, Denmark krif@steno.dk.
2: Steno Diabetes Center, Gentofte, Denmark.
3: Metabolic Unit, Institute of Neurosciences, Istituto Di Neuroscienze-Consiglio Nazionale Delle Ricerche, Padova, Italy.
4: Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
5: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
6: The Danish Diabetes Academy, Odense, Denmark.
7: Section of General Practice, Institute of Public Health, University of Aarhus, Aarhus, Denmark.
8: Division of Medicine, Lund University, Lund, Sweden.

Articles by these authors

Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet (2014) 1.92

Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study. PLoS Med (2014) 1.69

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes (2015) 1.65

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol (2013) 1.58

Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3. Diabetes (2014) 1.43

The genetic architecture of type 2 diabetes. Nature (2016) 1.43

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet (2015) 1.39

Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet (2015) 1.08

Prevalence of diabetes in Chinese adults. JAMA (2014) 1.01

Incidence of register-based diabetes 10 years after a stepwise diabetes screening programme: the ADDITION-Denmark study. Diabetologia (2016) 0.82

Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. Nat Commun (2017) 0.80

Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk. Endocrine (2016) 0.78

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans. Diabetes (2017) 0.78

Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia (2017) 0.75

Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis. Eur J Epidemiol (2016) 0.75

A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. Diabetes (2017) 0.75

SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. J Am Soc Nephrol (2016) 0.75

Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nat Med (2022) 0.75

Genetic Determinants of Electrocardiographic P-wave Duration and Relation to Atrial Fibrillation. Circ Genom Precis Med (2020) 0.75